Drugmaker 'shenanigans' blamed for lag in generic drug development

May 24, 2018 at 10:36 AM
Share & Print

More From HR Executive

NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Eli Lilly, Novo Nordisk, Sanofi sued over insulin prices Rural voters say health care policies fail to lower costs UnitedHealthcare, Cigna, Centene join new provider verification platform Senators reintroduce $1.3B health care cybersecurity bill Stop-loss premiums to rise 14.5% in 2027: Aegis Does private health insurance actually prevent medical debt?